Patents for C12N 9 - Enzymes, e.g. ligases (6.); Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating, or purifying enzymes (141,535)
07/2002
07/02/2002US6413559 Baked goods
07/02/2002US6413524 spsA polynucleotides and polypeptides
07/02/2002US6413521 Helminth parasite antigen with aminopeptidase-like activity
07/02/2002US6413512 Composition and method for treating disease by increasing activated α2 macroglobulin in the blood and extravascular tissue
07/02/2002CA2184908C Human osteoclast-derived cathepsin
07/02/2002CA2165839C Thermostable xylanase
07/02/2002CA2159083C Recombinant .alpha.-n-acetylgalactosaminidase enzyme and cdna encoding said enzyme
07/02/2002CA2050749C Nucleotide sequence coding for an outer membrane protein from neisseria meningitidis and use of said protein in vaccine preparations
07/02/2002CA2018149C Aminoketone compounds
06/2002
06/27/2002WO2002050309A2 A bardet-biedl susceptibility gene and uses thereof
06/27/2002WO2002050303A2 Protein-protein interactions
06/27/2002WO2002050294A1 A novel tissue specific plant promoter
06/27/2002WO2002050291A1 Hydrogen peroxide lyase regulatory region
06/27/2002WO2002050290A1 A yeast expression vector and a method of making a recombinant protein by expression in a yeast cell
06/27/2002WO2002050289A1 Methods for the production of multimeric proteins, and related compositions
06/27/2002WO2002050287A2 Multifunctional protease inhibitors and their use in treatment of disease
06/27/2002WO2002050286A2 Isolated human protease proteins, nucleic acid molecules encoding human protease proteins, and uses thereof
06/27/2002WO2002050285A2 Histone deacetylase-related gene and protein
06/27/2002WO2002050284A2 Oxidoreductases
06/27/2002WO2002050283A2 Isolated human drug-metabolizing proteins, nucleic acid molecules encoding human drug-metabolizing proteins, and uses thereof
06/27/2002WO2002050282A1 Novel thermostable galactose isomerase and tagatose production thereby
06/27/2002WO2002050267A1 Process for producing udp-n-acetylgalactosamine and saccharide containing n-acetylgalactosamine
06/27/2002WO2002050258A1 Novel aggrecanase
06/27/2002WO2002050257A2 Method for the production of polyfructans
06/27/2002WO2002050256A2 53010, a human carboxylesterase family member and uses thereof
06/27/2002WO2002050255A2 Isolated human dehydrogenases, nucleic acid molecules encoding them, and uses thereof
06/27/2002WO2002050254A2 Crystal structure of glycogen synthase kinase 3 beta
06/27/2002WO2002050253A1 A method for the purification of chymosin
06/27/2002WO2002050250A2 Signal-1/signal-2 bifunctional peptide inhibitors
06/27/2002WO2002050245A2 Novel cellulase producing actinomycetes, cellulase produced therefrom and method of producing same
06/27/2002WO2002050243A2 The use of ecm degrading enzymes for the improvement of cell transplantation
06/27/2002WO2002050163A2 Reduced byproduct high solids polyamine-epihalohydrin compositions
06/27/2002WO2002050109A2 Nucleic acids coding for vacuolar invertases, vegetal cells and plants containing said nucleic acids and the use thereof
06/27/2002WO2002050066A2 Pyrazole compounds useful as protein kinase inhibitors
06/27/2002WO2002050065A2 Pyrazole compounds useful as protein kinase inhibitors
06/27/2002WO2002049576A2 Fab i and inhibition of apicomplexan parasites
06/27/2002WO2002049423A1 Joint utilization of the insulin gene and the glucokinase gene in the development of therapeutic approaches for diabetes mellitus
06/27/2002WO2002034232A3 Use of carotenoids for treating ageing symptoms
06/27/2002WO2002029016A3 Thermostable polymerase based on thermococcus pacificus
06/27/2002WO2002026994A8 Manipulation of plant cell walls
06/27/2002WO2002024917A3 Method for modifying the genome of corynebacteria
06/27/2002WO2002020721A3 Vectors derived from south african arbovirus no. 86
06/27/2002WO2002020566A3 NOVEL MMP-2 DERIVATIVES FOR USE AS INHIBITORS OF INTEGRIN αVβ¿3?
06/27/2002WO2002016439A8 Novel nucleic acids and polypeptides
06/27/2002WO2002016415A3 Identification of a cam-kinase ii inhibitor
06/27/2002WO2002002597A3 Peptide extended glycosylated polypeptides
06/27/2002WO2002002053A3 Anticancer transgenic tomato
06/27/2002WO2002000703A3 REGULATION OF HUMAN GLUTAMYL-tRNA (Gln) AMIDOTRANSFERASE-LIKE ENZYME
06/27/2002WO2001097752A3 Compositions comprising urokinase for modulating muscle contractility and angiogenisis
06/27/2002WO2001096286A3 Urokinase inhibitors
06/27/2002WO2001090387A3 Gene regulatory region that promotes root-specific transcription and its uses
06/27/2002WO2001088107A3 Alpha-amylase variants with altered 1,6-activity
06/27/2002WO2001081555A3 Human kinases
06/27/2002WO2001073091A3 Methods of selection and development of plants having improved root quality and root lodging resistance
06/27/2002WO2001072975A3 Human methyl transferase family member, 25552, and uses thereof
06/27/2002WO2000063394A9 A polypeptide having amidolytic activity for a serpin
06/27/2002WO2000059924A9 Methods and reagents for modulating caspase-mediated apoptosis
06/27/2002WO2000056348A9 Inflammatory mediation obtained from atractylodes lancea
06/27/2002US20020083492 Basidiomycete peroxidase gene-transferred plant and a method for decomposing and removing hazardous chemicals using the same
06/27/2002US20020083484 Nucleotide sequences coding enzymatic polypeptide for use prevention of wilting in plants
06/27/2002US20020083480 Transgenic mice containing protein phosphatase 2C gene disruptions
06/27/2002US20020082408 GSK3 polypeptides
06/27/2002US20020082406 Novel human kinase interacting protein and polynucleotides encoding the same
06/27/2002US20020082404 Promoter sequences
06/27/2002US20020082403 Nucleotide sequences which code for the eno gene
06/27/2002US20020082401 Nucleotide sequences coding protein for use in treating eating disorder, autoimmune and viral diseases
06/27/2002US20020082397 Novel receptor-type phosphotyrosine phosphatase-kappa
06/27/2002US20020082392 Antibodies to cell-cycle regulatory proteins, and uses related thereto
06/27/2002US20020082234 Novel prokaryotic polynucleotides, polypeptides and their uses
06/27/2002US20020082231 Utilizing ratC polypeptides to screen for antibacterial compounds
06/27/2002US20020082212 7716, a novel human ATPase and uses therefor
06/27/2002US20020082203 Novel sphingosine kinases
06/27/2002US20020082194 Drug-metabolizing proteins that are related to the UDP-glucuronosyltransferase drug-metabolizing enzyme subfamily, recombinant DNA molecules and protein production
06/27/2002US20020082192 Contacting cell with compound that activates extracellular signal regulated kinase, p42/44MAPK, wherein activation of kinase results in induction of low density lipoprotein receptor expression; treatment of hypercholesterolemia
06/27/2002US20020082189 Amino acid sequences of the kinase peptides encoded by genes within the human genome; isolated peptide and nucleic acid molecules, methods of identifying orthologs, paralogs and modulators of the kinase peptides; anticarcinogenic agents
06/27/2002US20020082183 Including a non-porous or or minimally porous, low-density material, a binder, and an enzyme; for use in liquid detergents or cleaners; fast-release profile; wear resistance; nonsettling in suspensions; good appearance
06/27/2002US20020081739 Genetically engineering cells; obtain cell, obtain nucleotide sequences, adhere sequences to sheets, propel sheet into cells, recover transformed cells
06/27/2002US20020081730 HVD1 gene induced by salt stress
06/27/2002US20020081719 Inflammation inducible hybrid promoters, vectors comprising them and uses thereof
06/27/2002US20020081713 ADP-ribosylation factor-like proteins
06/27/2002US20020081712 Intensifying propagation of lactic acid bacteria; obtain lactic acid bacteria, incubate with lactic acid bacteria defective in pyruvate metabolism, propagate, recover bacteria
06/27/2002US20020081706 Negative strand rna viral vector having autonomous replication capability
06/27/2002US20020081705 Human caspase-14 compositions
06/27/2002US20020081704 Such as identifying modulators of the protease peptides for treating diseases; related to the ATP-dependent protease subfamily
06/27/2002US20020081703 Reducing allegenic response heterologous proteins; obtain nucleotide sequences of heterologous protein, insert subtilisin sequences, transform cell, expression vector, recover protein, monitor human to protein
06/27/2002US20020081702 Enzymatic polypetide for use in treatment of textiles, papermaking and animal feeds
06/27/2002US20020081699 Human lysophospholipase
06/27/2002US20020081697 Thermostable enzymes having aminotransferase activity, nucleic acids encoding them and methods of making and using them
06/27/2002US20020081695 Nucleotide sequences coding polypeptide for use in the treatment of blood disorders, gout, kidney stones, Lesch-Nyhan syndrome, renal failure and uricaciduria
06/27/2002US20020081694 Enzymatic polypeptide for use in the diagnosis and treatment of tumors
06/27/2002US20020081693 Plant caffeoyl-coa o-methyltransferase
06/27/2002US20020081692 Polypeptide for use as antitumor agent and wound healing agent
06/27/2002US20020081691 Delta 1-pyrroline-5-carboxylate reductase homolog
06/27/2002US20020081690 Hybrid enzyme and use thereof
06/27/2002US20020081689 Isolated human dehydrogenase proteins, nucleic acid molecules encoding these human dehydrogenase proteins, and uses thereof
06/27/2002US20020081686 Novel antimicrobial therapies
06/27/2002US20020081684 Method and nucleotide sequence for transforming microorganisms
06/27/2002US20020081682 Nucleotide sequences coding polypeptide for use in the diagnosis, prevention and treatment of bacterial infections
06/27/2002US20020081681 Nucleotide sequences coding enzymatic polypeptides for use in the treatment of kidney disorders
06/27/2002US20020081677 Ethanol production